Induction of transplantation tolerance in haploidenical transplantation under reduced intensity conditioning: The role of ex-vivo generated donor CD8 + T cells with central memory phenotype

Best Practice and Research: Clinical Haematology

Volumn 24, Issue 3, 2011, Pages 393-401

  Ophir, Eran ^a   Eidelstein, Yaki ^a   Bachar Lustig, Esti ^a   Hagin, David ^a   Or Geva, Noga ^a   Lask, Assaf ^a   Reisner, Yair ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Bone Marrow; Graft Versus Host Disease; Megadose

Indexed keywords

FAS LIGAND; INTERLEUKIN 15; INTERLEUKIN 2;

ARTICLE; BONE MARROW TRANSPLANTATION; CD19+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD34+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FRACTIONATION; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CENTRAL MEMORY PHENOTYPE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LEUKEMIA; LYMPHOCYTE SUBPOPULATION; MORTALITY; MYELOABLATIVE CONDITIONING; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; T CELL DEPLETED BONE MARROW TRANSPLANTATION; T LYMPHOCYTE; TRANSPLANT RELATED MORTALITY; TRANSPLANTATION TOLERANCE;

EID: 80053033385     PISSN: 15216926     EISSN: 15321924     Source Type: Journal    
DOI: 10.1016/j.beha.2011.05.007     Document Type: Review

References (69)

1. R.P. Gale, and Y. Reisner Graft rejection and graft-versus-host disease: mirror images Lancet 1 1986 1468 1470 (Pubitemid 16095654)
2. N.A. Kernan, N. Flomenberg, and B. Dupont Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes Transplantation 43 1987 842 847 (Pubitemid 17084261)
3. Y. Reisner, I. Ben-Bassat, and D. Douer Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation Proc Natl Acad Sci U S A 83 1986 4012 4015 (Pubitemid 16062412)
4. A. Terenzi, F. Aversa, and N. Albi Residual clonable host cell detection for predicting engraftment of T cell depleted BMTs Bone Marrow Transplant 11 1993 357 361 (Pubitemid 23162498)
5. T. Lapidot, A. Terenzi, and T.S. Singer Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts Blood 73 1989 2025 2032 (Pubitemid 19145141)
6. E. Bachar-Lustig, N. Rachamim, and H.W. Li Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice Nat Med 1 1995 1268 1273
7. L. Uharek, W. Gassmann, and B. Glass Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation Blood 79 1992 1612 1621
8. F. Aversa, A. Tabilio, and A. Terenzi Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum Blood 84 1994 3948 3955
9. Y. Reisner, and M.F. Martelli Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells Immunol Today 16 1995 437 440
10. F. Aversa, A. Terenzi, and A. Tabilio Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse J Clin Oncol 23 2005 3447 3454
11. I. Redei, A. Langston, and J. Cherry Haploidentical transplantation for adults with poor prognostic hematologic malignancies using the Perugia approach Leukemia 16 2002 414
12. T. Zuckerman, N. Haddad, and R. Elhasis Haploidentical transplantation - a single center experience Leukemia 16 2002 417
13. R. Handgretinger, T. Klingebiel, and P. Lang Haploidentical transplantation in children with hematological malignancies and non-malignant disorders. A single center 5-year experience Leukemia 16 2002 410
14. J. Cornish, N. Goulden, and C. Sewaard Haploidenticl stem cell transplantation in children Leukemia 6 2002 408
15. T. Klingebiel, P. Lang, and M. Schumm Haploidentical stem cell transplantation in children Leukemia 16 2002 410
16. N. Rachamim, J. Gan, and H. Segall Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture Transplantation 65 1998 1386 1393
17. R.G. Miller An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it Nature 287 1980 544 546 (Pubitemid 11232853)
18. H. Gur, R. Krauthgamer, and E. Bachar-Lustig Immune regulatory activity of CD34 + progenitor cells: evidence for a deletion-based mechanism mediated by TNF-alpha Blood 105 2005 2585 2593 (Pubitemid 40387063)
19. H. Gur, R. Krauthgamer, and A. Berrebi Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells Blood 99 2002 4174 4181 (Pubitemid 35332063)
20. Lior Zangi, Yaki Eidelstein, and Yael Klionsky Tolerance induction by immature dendritic cells is mediated by distinct MHC dependent and independent mechanisms: a novel role for perforin, granzyme A and toll like receptor 7 Blood 114 2009 a65 (ASH Annu Meet Abstracts)
21. S. Reich-Zeliger, E. Bachar-Lustig, and J. Gan Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. I. Relative reactivity of different veto cells J Immunol 173 2004 6654 6659 (Pubitemid 39541049)
22. P. Chrobak, and R.E. Gress Veto activity of activated bone marrow does not require perforin and Fas ligand Cell Immunol 208 2001 80 87
23. M.F. Martelli, F. Aversa, and E. Bachar-Lustig Transplants across human leukocyte antigen barriers Semin Hematol 39 2002 48 56 (Pubitemid 34081156)
24. R. Seggewiss, and H. Einsele Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update Blood 115 2010 3861 3868
25. D. Min, P.A. Taylor, and A. Panoskaltsis-Mortari Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation Blood 99 2002 4592 4600 (Pubitemid 34627232)
26. J.S. Sutherland, L. Spyroglou, and J.L. Muirhead Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade Clin Cancer Res 14 2008 1138 1149 (Pubitemid 351302562)
27. R.M. Kelly, S.L. Highfill, and A. Panoskaltsis-Mortari Keratinocyte growth factor and androgen blockade work in concert to protect against conditioning regimen-induced thymic epithelial damage and enhance T-cell reconstitution after murine bone marrow transplantation Blood 111 2008 5734 5744
28. A.M. Leen, A. Christin, and G.D. Myers Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation Blood 114 2009 4283 4292
29. T. Feuchtinger, K. Opherk, and W.A. Bethge Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation Blood 116 2010 4360 4367
30. K. Perruccio, F. Topini, and A. Tosti Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation Blood Cells Mol Dis 40 2008 76 83 (Pubitemid 350192305)
31. P.J. Amrolia, G. Muccioli-Casadei, and H. Huls Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation Blood 108 2006 1797 1808 (Pubitemid 44394986)
32. S.K. Tey, G. Dotti, and C.M. Rooney Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation Biol Blood Marrow Transplant 13 2007 913 924 (Pubitemid 47055386)
33. S. Kaneko, S. Mastaglio, and A. Bondanza IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes Blood 113 2009 1006 1015
34. K.K. Ballen, and T.R. Spitzer The great debate: haploidentical or cord blood transplant Bone Marrow Transplant 2010
35. B. Gyurkocza, A. Rezvani, and R.F. Storb Allogeneic hematopoietic cell transplantation: the state of the art Expert Rev Hematol 3 2010 285 299
36. M. Guo, Z. Sun, and Q.Y. Sun A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD Biol Blood Marrow Transplant 15 2009 930 937
37. P.V. O'Donnell, L. Luznik, and R.J. Jones Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using post transplantation cyclophosphamide Biol Blood Marrow Transplant 8 2002 377 386
38. H. Ogawa, K. Ikegame, and S. Yoshihara Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning Biol Blood Marrow Transplant 12 2006 1073 1084
39. W.A. Bethge, C. Faul, and M. Bornhauser Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update Blood Cells Mol Dis 40 2008 13 19 (Pubitemid 350192298)
40. P. Lang, M. Schumm, and J. Greil A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study Klin Padiatr 217 2005 334 338 (Pubitemid 41746115)
41. E. Ophir, and Y. Reisner Induction of tolerance in organ recipients by hematopoietic stem cell transplantation Int Immunopharmacol 9 2009 694 700
42. Y. Sharabi, and D.H. Sachs Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen J Exp Med 169 1989 493 502 (Pubitemid 19050646)
43. Y. Tomita, A. Khan, and M. Sykes Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen J Immunol 153 1994 1087 1098 (Pubitemid 24228500)
44. Y. Tomita, D.H. Sachs, and A. Khan Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation Transplantation 61 1996 469 477
45. T. Wekerle, J. Kurtz, and H. Ito Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment Nat Med 6 2000 464 469 (Pubitemid 30208167)
46. T. Kawai, A.B. Cosimi, and T.R. Spitzer HLA-mismatched renal transplantation without maintenance immunosuppression N Engl J Med 358 2008 353 361 (Pubitemid 351159234)
47. J.D. Scandling, S. Busque, and S. Dejbakhsh-Jones Tolerance and chimerism after renal and hematopoietic-cell transplantation N Engl J Med 358 2008 362 368 (Pubitemid 351159235)
48. E. Bachar-Lustig, H.W. Li, and H. Gur Induction of donor-type chimerism and transplantation tolerance across major histocompatibility barriers in sublethally irradiated mice by Sca-1(+)Lin(-) bone marrow progenitor cells: synergism with non-alloreactive (host x donor)F(1) T cells Blood 94 1999 3212 3221 (Pubitemid 29512731)
49. M.H. Claesson, and R.G. Miller Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. III. Direct correlation between development of syngeneic cytotoxicity and loss of veto activity; implications for the mechanism of veto action Scand J Immunol 29 1989 493 497 (Pubitemid 19110325)
50. M.H. Claesson, and C. Ropke Antiself suppressive (veto) activity of responder cells in mixed lymphocyte cultures Curr Top Microbiol Immunol 126 1986 213 223
51. P.J. Fink, H.G. Rammensee, and J.D. Benedetto Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes J Immunol 133 1984 1769 1774 (Pubitemid 14035263)
52. S. Reich-Zeliger, J. Gan, and E. Bachar-Lustig Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis J Immunol 173 2004 6660 6666 (Pubitemid 39541050)
53. + CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite Immunity 13 2000 507 515
54. O. Milstein, D. Hagin, and A. Lask CTLs respond with activation and granule secretion when serving target for T cell recognition Blood 2010
55. + thymocytes Blood 80 1992 2406 2411
56. P.J. Martin Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: potential role of a veto mechanism Blood 88 1996 962 969 (Pubitemid 26333320)
57. E. Bachar-Lustig, S. Reich-Zeliger, and Y. Reisner Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose Blood 102 2003 1943 1950 (Pubitemid 37122364)
58. + veto cells Transplantation 81 2006 88 94 (Pubitemid 43122154)
59. + T cells confer superior antitumor immunity compared with effector memory T cells Proc Natl Acad Sci U S A 102 2005 9571 9576 (Pubitemid 40981722)
60. N. Manjunath, P. Shankar, and J. Wan Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes J Clin Invest 108 2001 871 878 (Pubitemid 32880296)
61. + T cells competent to develop into memory cells that are activated in an antigen-free, IL-7- and IL-15-rich environment J Immunol 172 2004 7315 7323 (Pubitemid 38747591)
62. F. Sallusto, D. Lenig, and R. Forster Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 401 1999 708 712
63. W. Weninger, M.A. Crowley, and N. Manjunath Migratory properties of naive, effector, and memory CD8(+) T cells J Exp Med 194 2001 953 966 (Pubitemid 32953264)
64. E.J. Wherry, V. Teichgraber, and T.C. Becker Lineage relationship and protective immunity of memory CD8 T cell subsets Nat Immunol 4 2003 225 234 (Pubitemid 36322131)
65. K. Mueller, O. Schweier, and H. Pircher Efficacy of IL-2- versus IL-15-stimulated CD8 T cells in adoptive immunotherapy Eur J Immunol 38 2008 2874 2885
66. E. Ophir, Y. Eidelstein, and R. Afik Induction of tolerance to bone marrow allografts by donor-derived host nonreactive ex vivo-induced central memory CD8 T cells Blood 115 2010 2095 2104
67. F.D. Arditti, S. Aviner, and B. Dekel Eradication of B-CLL by autologous and allogeneic host nonreactive anti-third-party CTLs Blood 105 2005 3365 3371
68. P.G. Assaf Lask, Rinat Goren-Arbel, and Oren Milstein Eradication of B cell malignancies by anti-3rd party CTLs: a novel role for MHC class I Blood 10 2007 a2759 (ASH Annu Meet Abstracts)
69. E.O. Assaf Lask, Noga Or-Geva, and Adva Cohen Ex vivo generated donor central memory CD8 T Cells, previously shown to enhance engraftment of allogeneic bone marrow, also exhibit significant GVL activity without causing Gvhd in an in vivo b cell lymphoma model Blood 116 2010 a424 (ASH Annu Meet Abstracts)